Novel Chalcone Derivatives as Anti-Leishmania infantum Agents with Potential Synergistic Activity and In Silico Insights
Authors:
- Ana Letícia Monteiro FernandesAFAna Letícia Monteiro Fernandes
- Abraão Pinheiro SousaASAbraão Pinheiro Sousa
- Delva Thyares Fonseca LamecDLDelva Thyares Fonseca Lamec
- Leonardo Lima CardosoLCLeonardo Lima Cardoso
- Rosália Santos FerreiraRFRosália Santos Ferreira
- Shayenne Eduarda Ramos VanderleySVShayenne Eduarda Ramos Vanderley
- Petrônio Filgueiras Athayde-FilhoPAPetrônio Filgueiras Athayde-Filho
- Gabriela Fehn FissGabriela Fehn Fiss
- Tatjana Souza Lima KeesenTatjana Souza Lima Keesen
Open Access
- 7 November 2025
- journal article
- research article
- Published by MDPI AG in Antibiotics
- Vol. 14 (11) , 1123
Abstract
Background: Visceral leishmaniasis (VL) is a neglected tropical disease with limited therapeutic options, often restricted by toxicity, high costs, and resistance. Chalcones are promising scaffolds for the development of antiparasitic agents. Objectives: This study aimed to synthesize novel acetamides derived from 4-hydroxychalcones and evaluate their antileishmanial activity, cytotoxicity, potential synergy with amphotericin B (AmB), and mechanisms of action through in silico analyses. Methods: Six chalcone–acetamides (3a–c, 4a–c) were synthesized and characterized by IR, NMR, and HRMS. In vitro activity against Leishmania infantum promastigotes and axenic amastigotes was assessed by colorimetric assays. Cytotoxicity was tested in human erythrocytes and PBMCs. Synergy with AmB was analyzed by the combination index. Molecular docking targeted parasite enzymes, and ADMET tools predicted pharmacokinetic and safety profiles. Results: Phenyl-substituted derivatives (3a–c) were inactive, while cyclohexyl-substituted analogs (4a–c) were active. Compound 4b displayed the strongest effect (IC50: 7.02 μM for promastigotes, 3.4 μM for amastigotes), with low cytotoxicity and high Selectivity Indices. In combination with AmB, compound 4b reduced the effective dose (DRI: 2.87) and increased the therapeutic window. Docking revealed favorable interactions of compound 4b with deubiquitinase DUB16 and tryparedoxin peroxidase I, suggesting enzyme inhibition. ADMET predictions supported good absorption and low toxicity. Conclusions: Compound 4b demonstrated potent and selective antileishmanial activity, synergism with AmB, and predicted safety. These findings highlight chalcone derivative 4b as a promising lead for future preclinical development in VL therapy.Keywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (404927/2023-8)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Federal University of Paraíba (UFPB), Brazil
- FAPESQ-PB
This publication has 43 references indexed in Scilit:
- Synergistic activity between conventional antifungals and chalcone-derived compound against dermatophyte fungi and Candida spp.International Microbiology, 2024
- Synthesis and evaluation of hybrid sulfonamide‐chalcones with potential antileishmanial activityArchiv der Pharmazie, 2023
- Synthesis, characterization and evaluation of prenylated chalcones ethers as promising antileishmanial compoundsMolecular Diversity, 2022
- Amphotericin B: A drug of choice for Visceral LeishmaniasisActa Tropica, 2022
- Recent investigations into synthesis and pharmacological activities of phenoxy acetamide and its derivatives (chalcone, indole and quinoline) as possible therapeutic candidatesJournal of the Iranian Chemical Society, 2021
- Computer-aided discovery of two novel chalcone-like compounds active and selective against Leishmania infantumBioorganic & Medicinal Chemistry Letters, 2017
- The synthesis and synergistic antifungal effects of chalcones against drug resistant Candida albicansBioorganic & Medicinal Chemistry Letters, 2016
- Synthesis and evaluation of novel prenylated chalcone derivatives as anti-leishmanial and anti-trypanosomal compoundsBioorganic & Medicinal Chemistry Letters, 2015
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- Using AutoDock for Ligand‐Receptor DockingCurrent Protocols in Bioinformatics, 2008